title: Letter: Neutrophilic eccrine hidroadenitis with atypical findings.
abstract: Neutrophilic eccrine hidradenitis (NEH) was originally described as a distinctive dermatosis occurring in patients undergoing chemotherapy, especially associated with the use of cytarabine in the treatment of acute myelogenous leukemia (AML). This disorder is characterized by a neutrophilic infiltrate around the eccrine glands and coils and is associated with necrosis. However, atypical findings in the histology have been reported. To the best of our knowledge, leukocytoclastic vasculitis has not been described in association with NEH. We hypothesize that a toxic effect of cytarabine may damage the vessel wall to some extent, causing a vasculitic phenomenon.
authors.forename: Emiliano
authors.initials: E
authors.lastname: Grillo
authors.forename: Sergio
authors.initials: S
authors.lastname: Vano-Galvan
authors.forename: Carmen
authors.initials: C
authors.lastname: Gonzalez
authors.forename: Jaén
authors.initials: J
authors.lastname: Pedro
mesh_terms: D000328:Adult; D003561:Cytarabine / Q000009:adverse effects; D005260:Female; D016575:Hidradenitis / Q000139:chemically induced / Q000150:complications* / Q000473:pathology; D006801:Humans; D007948:Leukemia, Monocytic, Acute / Q000188:drug therapy; D009504:Neutrophils / Q000473:pathology; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000150:complications* / Q000473:pathology
chemical_list: D003561:Cytarabine